Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | TTR | P02766 | 1/20 | 0.58 |
| ▸ | ALB | P02768 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.45 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.45 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL10759274 | 0.89 | PTPN11 (0.48) | MEN1TTRALBKMT2AALOX15 | |
| SCHEMBL506682 | 0.84 | TTR (0.54) | MEN1TTRALBKMT2ACYP19A1 | |
| SCHEMBL7276752 | 0.84 | MMP3 (0.55) | MEN1TTRALBKMT2AALOX15 | |
| SCHEMBL6888576 | 0.83 | MEN1 (0.50) | MEN1TTRALBKMT2AALOX15 | |
| SCHEMBL5705421 | 0.81 | MEN1 (0.47) | MEN1TTRALBKMT2AALOX15 | |
| SCHEMBL5848625 | 0.81 | MEN1 (0.47) | MEN1TTRALBKMT2AALOX15 | |
| SCHEMBL29449995 | 0.78 | CA12 (0.52) | MEN1TTRALBKMT2AALOX15 | |
| SCHEMBL11017920 | 0.78 | MEN1 (0.52) | MEN1TTRALBKMT2ACA12 | |
| SCHEMBL217250 | 0.78 | CA12 (0.52) | MEN1TTRALBKMT2AALOX15 | |
| SCHEMBL23271632 | 0.76 | CA12 (0.50) | MEN1TTRALBKMT2AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118515534-B | Multi-tooth ligand, multi-tooth ligand metal catalyst, and preparation method and application thereof | 华南理工大学 | 2024-11-05 | — | — | CN | claimed |
| CN-118515534-A | Multi-tooth ligand, multi-tooth ligand metal catalyst, and preparation method and application thereof | 华南理工大学 | 2024-08-20 | — | — | CN | claimed |
| CN-105859583-B | A kind of synthetic method of the cyanophenol of 2,6 dibromo 4 | 衢州英特高分子材料有限公司 | 2018-01-16 | — | — | CN | claimed |
| US-9604929-B2 | Functionalized carbon nanoparticles and functional polymer fibers prepared using the same | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2017-03-28 | — | — | US | claimed |
| US-20150204009-A1 | FUNCTIONALIZED CARBON NANOPARTICLES AND FUNCTIONAL POLYMER FIBERS PREPARED USING THE SAME | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-07-23 | — | — | US | claimed |
| US-8945887-B2 | Whole cell biocatalyst | ZYRUS BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE I KG (DE) | 2015-02-03 | — | — | US | claimed |
| CN-103333134-A | 2-(3-cyano-4-alkoxy) phenyl-4-substituted thiazole-5-formic acid compound, composition as well as preparation methods and applications thereof | UNIV SHENYANG PHARMACEUTICAL | 2013-10-02 | — | — | CN | claimed |
| US-20130011890-A1 | WHOLE CELL BIOCATALYST | ZYRUS BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE I KG (DE) | 2013-01-10 | — | — | US | claimed |
| EP-2501807-A2 | WHOLE CELL BIOCATALYST | ZYRUS Beteiligungsgesellschaft mbH & Co. Patente I KG (DE) | 2012-09-26 | — | — | EP | claimed |
| WO-2011141933-A2 | PROCESS FOR PREPARATION OF 2-[3-CYANO-4-(2-METHYLPROPOXY)PHENYL]-4-METHYLTHIAZOLE-5-CARBOXYLIC ACID AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | MSN LABORATORIES LIMITED (IN) | 2011-11-17 | — | — | WO | claimed |
| EP-2338987-A1 | Whole cell biocatalyst | ZYRUS Beteiligungsgesellschaft mbH & Co. Patente I KG (DE) | 2011-06-29 | — | — | EP | claimed |
| WO-2011057820-A2 | WHOLE CELL BIOCATALYST | ZYRUS BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE I KG (DE) | 2011-05-19 | — | — | WO | claimed |
| CN-101863854-A | Synthesis method of 2-(3-cyan-4-isobutoxy) phenyl-4-methyl-5-thiazole formic acid | UNIV SHENYANG PHARMACEUTICAL | 2010-10-20 | — | — | CN | claimed |
| CN-101481329-A | Process for synthesizing aromatic diaidino intermediate diphenyl alkyl ether | NANJING SINO LION CHEMICAL CO (CN) | 2009-07-15 | — | — | CN | claimed |
| CN-122036560-A | Radioactive medical isotope18F-labeled norepinephrine analogue as well as preparation method and application thereof | 中国医学科学院阜外医院 | 2026-05-15 | — | — | CN | disclosed |
| US-20260085048-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | EPIVARIO INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260049074-A1 | THIADIAZOLYL DERIVATIVES | IDEAYA BIOSCIENCES, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| EP-0092632-A1 | New benzonitrile derivatives, method for their preparation and herbicidal compositions | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) | 1983-11-02 | — | — | EP | disclosed |
| EP-0080371-A1 | Diphenoxypropane derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1983-06-01 | — | — | EP | disclosed |
| US-3966850-A | INSECTICIDES, ACARACIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049074-A1 | THIADIAZOLYL DERIVATIVES | POLH, POLM, POLD1 | MEN1 4795/4885TTR 3748/4885ALB 4681/4885 |
| US-20260085048-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | ACSS2, GLS2, ACSL3 | MEN1 2249/4885TTR 4832/4885ALB 4047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.